Gene · 2192
Papers1,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phelan-McDermid Syndrome in Pediatric Patients With Novel Mutations: Genetic and Phenotypic Analyses. | Front Pediatr | 2022 | 36081626 | PubTator, text mining | PubMed |
| Proteomics Profiling of Osteoporosis and Osteopenia Patients and Associated Network Analysis. | Int J Mol Sci | 2022 | 36077598 | PubTator, text mining | PubMed |
| Decellularization of xenografted tumors provides cell-specific in vitro 3D environment. | Front Oncol | 2022 | 36059712 | PubTator, text mining | PubMed |
| Biochemical composition of the glomerular extracellular matrix in patients with diabetic kidney disease. | World J Diabetes | 2022 | 36051430 | PubTator, text mining | PubMed |
| Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment. | Front Endocrinol (Lausanne) | 2022 | 36046791 | PubTator, text mining | PubMed |
| Impact of a bisphenol A, F, and S mixture and maternal care on the brain transcriptome of rat dams and pups. | Neurotoxicology | 2022 | 36041667 | PubTator, text mining | PubMed |
| RNA helicase-dependent gene looping impacts messenger RNA processing. | Nucleic Acids Res | 2022 | 36039747 | PubTator, text mining | PubMed |
| Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants. | PLoS One | 2022 | 36037157 | PubTator, text mining | PubMed |
| Analysis of gene expression profile of peripheral blood in alveolar and cystic echinococcosis. | Front Cell Infect Microbiol | 2022 | 36034715 | PubTator, text mining | PubMed |
| Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors. | Cancer Discov | 2022 | 36027053 | PubTator, text mining | PubMed |
| Human Papillomavirus 16 E6 and E7 Oncoproteins Alter the Abundance of Proteins Associated with DNA Damage Response, Immune Signaling and Epidermal Differentiation. | Viruses | 2022 | 36016386 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy. | Cancers (Basel) | 2022 | 36010899 | PubTator, text mining | PubMed |
| Effects of Extracellular Vesicles from Osteogenic Differentiated Human BMSCs on Osteogenic and Adipogenic Differentiation Capacity of Naïve Human BMSCs. | Cells | 2022 | 36010568 | PubTator, text mining | PubMed |
| Quantitative bile and serum proteomics for the screening and differential diagnosis of primary sclerosing cholangitis. | PLoS One | 2022 | 36006970 | PubTator, text mining | PubMed |
| PlaqView 2.0: A comprehensive web portal for cardiovascular single-cell genomics. | Front Cardiovasc Med | 2022 | 36003902 | PubTator, text mining | PubMed |
| Comparative transcriptomic analysis of rabbit interscapular brown adipose tissue whitening under physiological conditions. | Adipocyte | 2022 | 36000239 | PubTator, text mining | PubMed |
| Proteomic Discovery and Validation of Novel Fluid Biomarkers for Improved Patient Selection and Prediction of Clinical Outcomes in Alzheimer's Disease Patient Cohorts. | Proteomes | 2022 | 35997438 | PubTator, text mining | PubMed |
| Cancer-Associated Stromal Fibroblast-Derived Transcriptomes Predict Poor Clinical Outcomes and Immunosuppression in Colon Cancer. | Pathol Oncol Res | 2022 | 35991839 | PubTator, text mining | PubMed |
| The plasma proteome is favorably modified by a high protein diet but not by additional resistance training in older adults: A 17-week randomized controlled trial. | Front Nutr | 2022 | 35990326 | PubTator, text mining | PubMed |
| Transposon-activated POU5F1B promotes colorectal cancer growth and metastasis. | Nat Commun | 2022 | 35987910 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2192/papers?page=19